Allogeneic Mesenchymal Stromal Cells (MSC) therapy (Institute Of Oncology Ljubljana)

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameAllogeneic Mesenchymal Stromal Cells (MSC) therapy (Institute Of Oncology Ljubljana)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsXerostomiaHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySlovenia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Oncology Ljubljana
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Oncology Ljubljana
Inactive CompaniesN/A
Active IndicationsXerostomiaHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A